Cargando…

Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

INTRODUCTION: Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an important marker of cardiovascular risk and a new target for therapeutic interventions. We aimed to study the influence of metformin on the level of circulating PCSK9 in patients with stable coronary artery disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shek, Aleksandr B., Alieva, Rano B., Kurbanov, Ravshanbek D., Hoshimov, Shavkat U., Nizamov, Ulugbek I., Ziyaeva, Adolat V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704763/ https://www.ncbi.nlm.nih.gov/pubmed/31448346 http://dx.doi.org/10.5114/amsad.2019.86752

Ejemplares similares

Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease
por: Shek, Aleksandr B., et al.
Publicado: (2017)

Personalized rosuvastatin therapy in problem patients with partial statin intolerance
por: Shek, Aleksandr B., et al.
Publicado: (2018)

E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach?
por: Alieva, Rano, et al.
Publicado: (2023)

Plasmonic detection and visualization of directed adsorption of charged single nanoparticles to patterned surfaces
por: Scherbahn, Vitali, et al.
Publicado: (2016)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
por: Ikegami, Yuichi, et al.
Publicado: (2018)

Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
por: Choi, Jah Yeon, et al.
Publicado: (2019)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
por: Caselli, Chiara, et al.
Publicado: (2019)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
por: Mayne, Janice, et al.
Publicado: (2008)

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
por: Sliz, Eeva, et al.
Publicado: (2018)

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021)

Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
por: Wang, Qiang, et al.
Publicado: (2022)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
por: LIU, Yu-Qi, et al.
Publicado: (2021)

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study
por: Xu, Mingtong, et al.
Publicado: (2022)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents
por: Wang, Shuai, et al.
Publicado: (2022)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
por: Cerit, L., et al.
Publicado: (2016)

May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
por: Scicali, Roberto, et al.
Publicado: (2020)

Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance
por: Shu, Xin, et al.
Publicado: (2022)

Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021)

Coronary revascularization in the elderly with stable angina
por: Kozlov, Kirill Lenarovich, et al.
Publicado: (2015)

PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy
por: Mäkelä, Kari A., et al.
Publicado: (2021)

Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins
por: Veselka, Josef, et al.
Publicado: (2011)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
por: Zulkapli, Rahayu, et al.
Publicado: (2023)

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
por: Hopewell, Jemma C, et al.
Publicado: (2018)

Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
por: Choi, Mihong, et al.
Publicado: (2021)

Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
por: Bak, Keunhyeong, et al.
Publicado: (2023)

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway
por: Zhu, Wenqiang, et al.
Publicado: (2022)

PCSK9 Inhibitors in a Statin-Intolerant Transgender Man With Heterozygous Familial Hypercholesterolemia: A Case Report
por: Pirazzi, Carlo, et al.
Publicado: (2019)

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
por: Zhang, Liwen, et al.
Publicado: (2012)

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol
por: Lee, Soo Youn, et al.
Publicado: (2016)

The effect of temperature on the stability of PCSK-9 monoclonal antibody: an experimental study
por: Kongmalai, Tanawan, et al.
Publicado: (2021)

The Effect of Temperature on the Stability of PCSK-9 Monoclonal Antibody: An Experimental Study
por: Kongmalai, Tanawan, et al.
Publicado: (2021)

Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density
por: Lee Argov, Erica J., et al.
Publicado: (2020)

Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High‐Dose Statin Therapy
por: Raal, Frederick, et al.
Publicado: (2013)

Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
por: Wu, Lingshan, et al.
Publicado: (2023)

Case report: Intensive statin and PCSK-9 inhibitor combo reduces plaque volume and stenosis in ischemic stroke patient
por: Zeng, Weiqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vlklb3b947n6ipkqkgecq3g7ah